Stockscreener 앱 받기
4.16
9.37%
-0.43
시간 외 거래:
4.16
전일 마감가:
$4.59
열려 있는:
$4.39
하루 거래량:
540.57K
Relative Volume:
0.72
시가총액:
$230.75M
수익:
$163.78M
순이익/손실:
$25.88M
주가수익비율:
6.40
EPS:
0.65
순현금흐름:
$-28.66M
1주 성능:
-10.73%
1개월 성능:
-14.40%
6개월 성능:
+14.29%
1년 성능:
-37.44%
1일 변동 폭
$4.15
$4.49
1주일 범위
$4.15
$4.725
52주 변동 폭
$2.645
$7.4436
Voyager Therapeutics Inc Stock (VYGR) Company Profile
명칭
Voyager Therapeutics Inc
전화
857-259-5340
주소
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.16 | 254.60M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 개시 | Citigroup | Buy |
| 2024-11-29 | 재개 | Wedbush | Outperform |
| 2024-10-16 | 개시 | Leerink Partners | Outperform |
| 2024-03-26 | 개시 | Guggenheim | Buy |
| 2024-03-19 | 개시 | H.C. Wainwright | Buy |
| 2024-03-07 | 개시 | Citigroup | Buy |
| 2024-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 개시 | Truist | Buy |
| 2023-03-10 | 개시 | Oppenheimer | Outperform |
| 2021-10-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-02-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-24 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-11-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 개시 | Oppenheimer | Outperform |
| 2018-11-15 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-09-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 개시 | H.C. Wainwright | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-03-12 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-02-02 | 개시 | Morgan Stanley | Overweight |
| 2017-11-28 | 재개 | Piper Jaffray | Overweight |
| 2017-10-31 | 개시 | Robert W. Baird | Outperform |
| 2017-10-27 | 개시 | Canaccord Genuity | Buy |
| 2017-10-23 | 재확인 | Stifel | Buy |
| 2017-10-12 | 개시 | Raymond James | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-28 | 재개 | Stifel | Buy |
모두보기
Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스
Key resistance and support levels for Voyager Therapeutics Inc.Bull Run & Risk Managed Trade Strategies - newser.com
Can Voyager Therapeutics Inc. stock hit record highs againJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Sentiment analysis tools applied to Voyager Therapeutics Inc.Earnings Overview Report & Precise Buy Zone Tips - newser.com
Is Voyager Therapeutics Inc. stock a buy in volatile marketsWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Using R and stats models for Voyager Therapeutics Inc. forecasting2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
Developing predictive dashboards with Voyager Therapeutics Inc. dataJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Using portfolio simulators with Voyager Therapeutics Inc. included2025 Dividend Review & Weekly Market Pulse Updates - newser.com
Has Voyager Therapeutics Inc. formed a bullish divergenceEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Is Voyager Therapeutics Inc. a candidate for recovery playJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Multi asset correlation models including Voyager Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - newser.com
How high can Voyager Therapeutics Inc. stock goMarket Trend Review & Advanced Swing Trade Entry Alerts - newser.com
What drives Voyager Therapeutics Inc stock priceConsumer Goods Stocks & Free Daily Market Summary and Trend Reports - earlytimes.in
How institutional ownership impacts Voyager Therapeutics Inc. stock2025 Price Targets & Capital Protection Trade Alerts - newser.com
Is Voyager Therapeutics Inc. stock attractive after correctionEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Voyager Therapeutics Advances Alzheimer’s Study with VY7523 - MSN
Voyager Therapeutics Stock Lost 5.1%, Buy Or Wait? - Trefis
Owning 44% shares,institutional owners seem interested in Voyager Therapeutics, Inc. (NASDAQ:VYGR), - Yahoo Finance
Can Voyager Therapeutics Inc. stock hit analyst price targetsProduct Launch & Safe Entry Momentum Tips - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock compares to market leadersJuly 2025 Decliners & AI Driven Price Forecasts - fcp.pa.gov.br
How Voyager Therapeutics Inc. stock benefits from tech adoption2025 Price Targets & Free Community Supported Trade Ideas - Fundação Cultural do Pará
How to recover losses in Voyager Therapeutics Inc. stockJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Voyager Therapeutics Inc (VYGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):